PA 452
Modify Date: 2025-08-26 09:56:02
PA 452 structure
|
Common Name | PA 452 | ||
|---|---|---|---|---|
| CAS Number | 457657-34-0 | Molecular Weight | 439.59 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H37N3O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PA 452PA452, retinoic X receptor (RXR) specific antagonist, inhibits the effect of Retinoic acid (RA) on Th1/Th2 development[1]. |
| Name | PA452 |
|---|
| Description | PA452, retinoic X receptor (RXR) specific antagonist, inhibits the effect of Retinoic acid (RA) on Th1/Th2 development[1]. |
|---|---|
| Related Catalog | |
| Target |
RXR |
| In Vitro | PA452 inhibits the Troglitazone (TZ)-induced CK13 expression[2]. PA452 (0.01, 0.1, and 1 μM) inhibits RXR in normal human urothelial (NHU) cells[2]. |
| References |
| Molecular Formula | C26H37N3O3 |
|---|---|
| Molecular Weight | 439.59 |